Note: Avadim Technologies's revenues are gauged from an analysis of company filings.
Avadim Technologies has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
December 5, 2017
Complete list of funding rounds and total amounts in the Company Report
Avadim Technologies's Income Statement (based on Industry Averages)
$ Millions (Industry Average)
Avadim Technologies Revenue (Sales)
Cost of Goods Sold
Salaries and wages
Other Operating Expenses
Total Operating Expenses
EBIT (Earnings Before Interest and Taxes)
Trademark applications show the products and services that Avadim Technologies is developing and marketing.
Avadim Technologies's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets.
Trademarks may include brand names, product names, logos and slogans.
[PH]UEL5.0 Medicated solutions for topical application to treat skin and muscular conditions
COMBAT ONE Topical cosmetic solutions for personal use for hygiene and skin cleansing
X Topical medical solutions to treat a variety of skin and muscular conditions by improving tissue function of both intact and damaged skin, the underlying capillary bed, and associated muscular tissues
Patent applications show Avadim Technologies's intellectual property,
its current capabilities and future direction.
Avadim Technologies has applied for 4 patents since 2009.
Avadim Technologies's most recent patent was filed in May 2017 for Method For Improving Health Outcomes.Method of using an antiseptic and pH modulating solution provides improved health outcomes in part by decolonizing surfaces, animate and inanimate, and improving tissue function and stress response, particularly the barrier properties and antimicrobial properties of tissues, especially skin and muscles, whether damaged or intact and at risk of damage. The method includes initial application followed by continued topical application on a periodic basis until the damaged area is restored or the risk of injury has passed, followed by continued maintenance application for a period of time thereafter. The method of using the solution is believed to restore and improve the functioning of tissues that naturally interrupt pathogenic mechanisms of disease in addition to providing antimicrobial support. The method can be adapted to improve a plurality of health or consumer care outcomes, from preventing or substantially reducing rates of hospital acquired infections to improving muscle performance and recovery, among others.
Complete list of patent applications
Determine whether Avadim Technologies grew or shrank during the last recession. This is useful in estimating the
financial strength and credit risk of the company.
Compare how recession-proof Avadim Technologies is relative to the industry overall.
While a new recession may strike a particular industry, measuring the
industry and company's robustness during the last recession estimates its ability to weather future recessions.
Market Share of Competition: Avadim Technologies vs. Largest Competitors
A competitive analysis shows these companies are in the same general field as Avadim Technologies, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Avadim Technologies.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Avadim Technologies and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.